Marshall is a Senior Research Analyst for Health Care at ClearBridge Investments. He joined ClearBridge in 2008 and has 25 years of investment industry experience.
Prior to joining ClearBridge, Marshall was a Health Care Analyst on the Large Cap Growth Team at Bear Stearns Asset Management. He was previously a Senior Analyst covering medical supplies & devices and an Associate Analyst covering U.S. major pharmaceuticals at Credit Suisse; an Associate Analyst covering global biotechnology at Sanford C. Bernstein; and an Associate in the Life Sciences Group at Lazard Freres.
Marshall received an M.B.A. from The University of Chicago and a B.S. in finance from The Wharton School of the University of Pennsylvania.
Marshall’s key ESG considerations for the health care sector include access to medicines; addressing unmet medical needs; governance (especially capital allocation and executive compensation); drug safety and efficacy; ethical sales and marketing practices.
Experience
- 25 years of investment industry experience
- Joined ClearBridge Investments in 2008
- Bear Stearns Asset Management - Health Care Analyst, Large Cap Growth Team
- Credit Suisse – Senior Analyst, Medical Supplies & Devices
- Credit Suisse – Associate Analyst, U.S. Major Pharmaceuticals
- Sanford C. Bernstein – Associate Analyst, Global Biotechnology
- Lazard Freres – Associate, Life Sciences Group
- M.B.A. from The University of Chicago
- B.S. in finance from The Wharton School of the University of Pennsylvania